Ballast Small/Mid Cap ETF MGMT 深 沪
已收盘 08-29 16:00:00 美东时间
44.2148
-0.199
-0.45%
华盛通- 最 高44.2828
- 今 开44.17
- 成交量 3972股
- 最 低 44.14
- 昨 收 44.4138
- 总市值 1.72亿
- 52周最高 44.48
- 市盈率 静 --
- 换手率 0.10%
- 52周最低 32.09
- 委 比 -3.64%
- 总股本 390.02万
- 历史最高 44.48
- 量 比 0.68
- 振 幅 0.32%
- 历史最低 24.2839
- 每 手 1
- 风险率 2.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GEO Missed Q1 Targets On Rising Costs And Debt, Guides Q2 Below Street Estimates
GEO Group reported lower Q1 revenue and adjusted EBITDA, missing consensus. EPS also fell short. Outlook raised for FY25 but Q2 expectations lowered.
05-07 23:32
GEO Q4 Earnings: Sales Beat, EPS Miss, New Immigration Contract And More
The GEO Group reported lower adjusted EBITDA and EPS for Q4 2024, but surpassed revenue expectations. FY25 outlook is below consensus, but company plans to reduce debt and has secured a $1 billion contract with ICE for its Delaney Hall facility.
02-27 21:44
Merck buys Modifi for $30M plus up to $1.3B in potential payments
Merck (NYSE:MRK) has acquired Modifi Biosciences, a developer of DNA modification-enabled cancer drugs, for $30M upfront and up to $1.3B in potential milestone payments. Modifi, a spinout of Yale Univ...
2024-10-23 23:43
阿斯利康(AZN.US)在研ATM激酶抑制剂1期试验显示积极结果
日前，阿斯利康(AZN.US)在美国癌症研究协会(AACR)年会上公布其在研ATM激酶抑制剂AZD1390全球1期试验的积极结果。
2024-04-11 10:20
AZZ Eyes Growth Spurt: Strong Markets Fuel FY25 Sales, Profit Forecast
AZZ raises FY25 guidance due to strength in several end markets. Sales outlook increased to $1.525-$1.625B, adjusted EPS to $4.50-$5.00, and adjusted EBITDA to $310-$360M. Company plans to report Q4 results on April 22, 2024.
2024-04-08 20:43
CNS Pharmaceuticals Presents Updated Results From On-Going Potentially Pivotal Study Of Berubicin In Adult Patients With Recurrent GBM After Failure Of Standard First Line Therapy
Data presented at the 2023 SNO/ASCO CNS Cancer Conference Berubicin currently being evaluated in an ongoing potentially pivotal study for the treatment of Glioblastoma Multiforme (GBM) with topline data from interim
2023-08-14 21:10
HORIZON CD(9930.HK):1H23 CORE PROFIT +10% YOY; POSITIVE ON THE STRUCTURAL GROWTH AND MGMT. EXECUTION
Horizon's reported net profit in 1H23 came in at RMB237mn, up 49% YoY. Excludin...
2023-08-09 01:52
埃斯顿：Avanda Invt Mgmt- SG、CHINA GALAXY ASSET MGMT- HK等11家机构于6月8日调研我司
2022年6月10日埃斯顿（002747）发布公告称：Avanda Invt Mgmt- SG、CHINA GALAXY ASSET MGMT- HK、FOORD ASSET MGMT- SG、HANG SENG INVESTMENT MANAGEMENT- HK、Kenrich Partners- SG、Matthews International Capital Manag...
2022-06-11 04:21
